X0306 4 2022-04-18 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856369 Gibson Christopher C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 1 0 0 Chief Executive Officer Class A Common Stock 2022-04-18 4 M 0 44010 2.48 A 412127 D Class A Common Stock 2022-04-18 4 S 0 17336 6.9898 D 394791 D Class A Common Stock 2022-04-18 4 C 0 18500 0.00 A 413291 D Class A Common Stock 2022-04-18 4 S 0 18500 6.6971 D 394791 D Class A Common Stock 2022-04-18 4 C 0 500 0.00 A 500 I by LAHWRAN-3 LLC Class A Common Stock 2022-04-18 4 S 0 500 6.7156 D 0 I by LAHWRAN-3 LLC Class A Common Stock 2022-04-18 4 C 0 1000 0.00 A 1000 I by LAHWRAN-4 LLC Class A Common Stock 2022-04-18 4 S 0 1000 6.7064 D 0 I by LAHWRAN-4 LLC Class A Common Stock 2022-04-18 4 C 0 1000 0.00 A 1000 I by Gibson Family Trust Class A Common Stock 2022-04-18 4 S 0 1000 6.7062 D 0 I by Gibson Family Trust Class B Common Stock 0.00 2022-04-18 4 C 0 18500 0.00 D Class A Common Stock 6929834 6929834 D Stock Option (Right to Buy) 11.40 2032-02-04 Class A Common Stock 416350 416350 D Stock Option (Right to Buy) 11.40 2022-02-04 2032-02-04 Class A Common Stock 5436 5436 D Stock Option (Right to Buy) 2.48 2022-04-18 4 M 0 44010 0.00 D 2030-12-30 Class A Common Stock 1207294 1207294 D Class B Common Stock 0.00 2022-04-18 4 C 0 500 0.00 D Class A Common Stock 547000 547000 I by LAHWRAN-3 LLC Class B Common Stock 0.00 2022-04-18 4 C 0 1000 0.00 D Class A Common Stock 544000 544000 I by LAHWRAN-4 LLC Class B Common Stock 0.00 2022-04-18 4 C 0 1000 0.00 D Class A Common Stock 140875 140875 I by Gibson Family Trust Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $6.98 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Represents the conversion of Class B Common Stock into Class A Common Stock. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. This transaction was executed in multiple trades at prices ranging from $6.46 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $6.46 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $6.47 to $7.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $6.46 to $7.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. /s/ Nathan Hatfield, attorney-in-fact 2022-04-20